Assessment of human allergic diseases

Clinical Immunology: Principles and Practice Expert Consult: Online and Print

Volumn , Issue , 2008, Pages 1471-1484

  Hamilton, Robert G ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011720363     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04404-2.10100-9     Document Type: Chapter

References (60)

1. Prausnitz C., Kustner H. Studine uber die Ueberemfindlichkeil. Zentrabl Bakteriol Mikrobiol Hyg 1921, 86:160.
2. Ishizaka K., Ishizaka T. Physiochemical properties of reaginic antibody. I. Association of reaginic activity with an immunoglobulin other than gamma A or gamma G globulin. J Allergy 1967, 37:169.
3. Johansson S.G.O. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967, 2:951.
4. Hamilton R.G. The science behind the discovery of IgE. J Allergy Clin. Immunol 2005, 115:648.
5. Hamilton R.G. Human immunoglobulins. Handbook of human immunology 1998, 65-109. CRC Press, Boca Raton. M.S. Leffell, N. Rose (Eds.).
6. Barbee R.A., Halomen M., Lebowitz M., et al. Distribution of IgE in a community population sample: correlations with age, sex and allergen skin test reactivity. J Allergy Clin Immunol 1981, 68:106.
7. Wittig H.J., Belloit J., DeFillippi I., et al. Age-related serum IgE levels in healthy subjects and in patients with allergic disease. J Allergy Clin Immunol 1980, 66:305.
8. Dati F., Ringel K.P. Reference values for serum IgE in healthy nonatopic children and adults. Clin Chem 1982, 28:1556.
9. Cameron L., Vercelli D. Synthesis and regulation of immunoglobulin E. Allergy: principles and practice 2003, 87. Mosby, Philadelphia. 6 th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
10. Lin H., Boesel K.M., Griffith D.T., et al. Omalizumab rapidly decreases nasal allergic response and Fc?R1 on basophils. J Alllergy Clin Immunol 2004, 113:297.
11. Wide L., Bennich H., Johansson S.G.O. Diagnosis by an in vitro test for allergen specific antibodies. Lancet 1967, 2:1105.
12. Yunginger J.W., Ahlstedt S., Eggleston P.A., et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol 2000, 105:1077.
13. Hamilton R.G. Diagnostic methods for insect sting allergy. [Review]. Curr Opin Allergy Clin Immunol 2004, 4:297.
14. Hamilton R.G., Adkinson N.F. In vitro assays for IgE mediated sensitivities. [Review] J Allergy Clin Immunol 2004, 114:213-225.
15. Guerin B., Watson R.D. Skin tests. Clin Rev Allergy 1988, 6:211.
16. DemolyPiette P.V., Bousquet J. In vivo methods for study of allergy: Skin tests, techniques and interpretation. Allergy: principles and practice 2003, 631. Mosby, Philadelphia. 6 th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
17. Nelson H.S. In vivo testing for immunoglobulin E mediated sensitivity. Pediatric allergy: principles and practice 2003, 243. Mosby, Philadelphia. D.Y.M. Leung, H.A. Sampson, R.S. Geha, S.J. Szefler (Eds.).
18. Turkeltaub P.C., Rastogi S.C., Baer H., et al. A standardized quantitative skin test assay of allergen potency and stability. Studies on the allergen dose-response curve and effect of wheal, erythema and patient selection on assay results. J Allergy Clin Immunol 1982, 70:343.
19. Fish J.E., Peters S.P. Bronchial challenge testing. Allergy: principles and practice 2003, 657. Mosby, Philadelphia. 6 th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
20. Rajakulasingam K. Nasal provocation testing. Allergy: principles and practice 2003, 644. Mosby, Philadelphia. 6 th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
21. Kurtz K.M., Hamilton R.G., Adkinson N.F. Role and application of provocation in the diagnosis of occupational latex allergy. Ann Allergy Asthma Immunol 1999, 83:634.
22. Pipkorn U., Granerus G., Proud D. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy 1987, 42:496.
23. Sampson H.A. Adverse reactions to foods. Allergy: principles and practice 2003, 1619. Mosby, Philadelphia. 6 th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
24. Bock S.A., Sampson H.A., Atkins F.M., et al. Double-blind placebo controlled food challenge as an office procedure: a manual. J Allergy Clin Immunol 1988, 82:986.
25. Sampson H.A. Utility of food specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001, 107:891.
26. Diagnostic Allergy [SE-A-2006] Proficiency Survey Participant Summary, College of American Pathologists (CAP).325 Waukegan Road, Northfield, IL 60093-2750: p 1-21.
27. Hamilton R.G., Marcotte G.V., Saini S.S. Immunological methods for quantifying free and total serum IgE in asthma patients receiving Omalizumab (Xolair) therapy. J Immunol Meth 2005, 303:81-91.
28. Hamilton R.G. Accuracy of Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (Omalizumab). J Allergy Clin Immunol 2006, 117:759-766.
29. National Committee on Clinical Laboratory Standards [currently Clinical and Laboratory Standards Institute] (Matsson P, Hamilton RG, eds) Evaluation methods and analytical performance characteristics of immunological assays for human IgE antibody of defined allergen specificities: approved guideline 1/LA20-A, 1997.
30. Hamilton R.G., Butler J.E. Quantitation of specific antibodies: methods of expression, standards solid phase considerations and specific applications. Immunochemistry of solid phase immunoassays 1991, CRC Press, Boca Raton, Chapter 9. J.E. Butler (Ed.).
31. Kober A., Perborn H. Quantitation of mouse-human chimeric Allergen-specific IgE antibodies with ImmunoCAP technology. J Allergy Clin Immunol 2006, 117:S219. [Abstract 845].
32. Jahn-Schmid B., Harwanegg C., Hiller R., et al. Allergen microarray: comparison to microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy 2003, 33:1443-1449.
33. Nystrand M., Kober A., Stderstrom L. A semi-quantitative point of care (POC) test for rapid detection of specific IgE antibodies. J Allergy Clin Immunol 2006, 117:S219. [Abstract 844].
34. Wood R.A., Segall N., Ahlstedt S., Williams P.B. Accuracy of IgE antibody laboratory results. Ann Allergy Asthma Immunol 2007, 99:34-41.
35. Hamilton R.G., Wisenauer J.A., Golden D.B., et al. Selection of Hymenoptera venoms for immunotherapy based on patient's IgE antibody crossreactivity. J Allergy Clin Immunol 1993, 92:651.
36. Lichtenstein L.M., Norman P.S., Winkenwerder W.L. A single year of immunotherapy of ragweed hay fever: immunologic and clinical studies. Ann Intern Med 1971, 75:663.
37. Golden D.B.K., Lawrence I.D., Hamilton R.G., et al. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy. J Allergy Clin Immunol 1992, 90:386.
38. Craig C.S., Schwartz L.B. Tryptase and chymase: markers of distinct types of human mast cells. Immunol Res 1989, 8:130.
39. Enander I., Matsson P., Anderson A.S., et al. A radioimmunoassay for human serum tryptase released during mast cell activation. J Allergy Clin Immunol 1990, 85:154-159.
40. Van der Linden P.W., Hack C.E., Poortman J., et al. Insect sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992, 90:110-118.
41. Miller J.S., Schwartz L.B. Tryptase levels as an indication of mast cell activation in a patient with Hymenoptera anaphylaxis and mastocytosis. N Engl J Med 1987, 316:1622.
42. Schwartz L.B. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006, 26:451-463.
43. Lichtenstein L.M., Osler A.G. Studies on the mechanisms of hypersensitivity phenomenon. IX. Histamine release from human leukocytes by ragweed pollen. J Exp Med 1964, 120:507.
44. Siraganian R.P. Automated histamine analysis for in vitro allergy testing. II. Correlation of skin test results with in vitro whole blood histamine release in 82 patients. J Allergy Clin Immunol 1977, 59:214.
45. Wegner F., Hockamp R., Rutschke A., et al. Superiority of the histamine release test above case history, prick test and radioallergosorbent test in predicting bronchial reactivity to the house dust mite in asthmatic children. Klin Wochenschr 1983, 61:43.
46. de Weck A.L. Cellular allergen stimulation test (CAST): a new dimension in allergy diagnostics. ACI News 1993, 1/5:9-14.
47. Maly F.E., Marti-Wyss S., Blumber S., et al. Mononuclear blood cell sulpholeukotriene generation in the presence of interleukin 3 and whole blood histamine release in honeybee and yellow jacket venom allergy. J Invest Allergy Clin Immunol 1997, 7:217-224.
48. Moneret-Vautrin D.A., Sainte-Laudy J., Kanny G., Fremont S. Human basophil activation as measured by CD63 expression and LTC4 release in IgE mediated food allergy. Ann Allergy Asthma Immunol 1999, 82:33.
49. Bochner B.S., Sterbinsky S.A., Saini S.A., et al. Studies of cell adhesion and flow cytometric analyses of degranulation, surface phenotype and viability using human eosinophils, basophils and mast cells. Methods 1997, 13:61-68.
50. Sanz M.L., Gamboa P.M., Antepara I. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate type reactions to beta lactam antibiotics. Clin Exp Allergy 2002, 32:277-286.
51. Buhring H.J., Sieffert M., Giesert C. The basophil activation marker defined by antigen 97A6 is identical to ectonucleotide pyrophosphate/phosphodiesterase 3. Blood 2001, 97:3303-3305.
52. Platz I., Binder M., Marxer A., et al. Hymenoptera venom induced up regulation of basophil activation marker ecto-nucleotide pyrophosphatase/phosphoesterase 3 (E-NNP3, CD203c) in sensitized individuals. Int Arch Allergy Immunol 2001, 126:335-342.
53. Ebo D.G., Hagendorens M.M., Bridts C.H., et al. In vitro allergy diagnosis: should we follow the flow?. [Review] Clin Exp Allergy 2004, 34:332-339.
54. Hallgren R., Bigelle A., Veuge P. Eosinophil cationic protein in inflammatory effusions as evidence of eosinophil involvement. Ann Rheum Dis 1984, 43:556.
55. Fink J.N., Zacharisen M.C. Hypersensitivity pneumonitis. Middleton's allergy: principles and practice 2003, 1373. Mosby, St Louis. 6th edn. N.F. Adkinson, J.W. Yunginger, W.W. Busse (Eds.).
56. Jarvis M.J., Tunstall-Pedoe H., Feyerabend C., et al. Comparisons of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987, 77:1435.
57. Haley N.J., Sepkovic D.W., Hoffmann D. Elimination of cotinine from body fluids: disposition in smokers and nonsmokers. Am J Public Health 1989, 79:1046.
58. Hamilton R.G. Assessment of indoor allergen exposure. Curr Allergy Asthma Rep 2005, 5:394-401.
59. Pate A.D., Hamilton R.G., Ashley P.J., et al. Proficiency testing of allergen measurements in residential dust. J Allergy Clin Immunol 2005, 116:844-850.
60. Hamilton R.G., Chapman M.D., Platts-Mills T.A.E., Adkinson N.F. House dust aeroallergen measurements in clinical practice: A guide to allergen-free home and work environments. Immunol Allergy Pract 1992, 14:9.